Form 4 for CTNM Contineum Therapeutics, Inc.
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-11 · accession 0001437749-26-004126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-11 | CTNM | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $1.26 | +400 | 15.4K | +3% | +$504 |
| D | 2026-02-13 | 2026-02-11 | CTNM | Stengone Carmine N. | CEO, Pres, Dir | S - Sale+OE | $16.00 | -400 | 15.0K | -3% | -$6,400 |
| D | 2026-02-13 | 2026-02-11 | CTNM | Stengone Carmine N. | CEO, Pres, Dir | M - OptEx | $0.00 | -400 | 128.0K | -0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-11 | M | A | 400 | $1.26 | 15,354 | D | — | — | (F2) Includes 1,246 shares purchased through Issuer's Employee Stock Purchase Plan on November 15, 2024 and 2,096 shares purchased through Issuer's Employee Stock Purchase Plan on May 15, 2025. |
| 2 | Common | Class A Common Stock | 2026-02-11 | S | D | 400 | $16.00 | 14,954 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-11 | M | D | 400 | $0.00 | 128,017 | D | $1.26 · — to 2028-11-13 | 400 Class A Common Stock | (F3) The stock options are fully vested and exercisable. |